Formulation of a corticosteroid drug in nanostructured lipid carrier /
Fatma Samir Abdelsalam Elsebaei
Formulation of a corticosteroid drug in nanostructured lipid carrier / صياغة احد الكورتيكوستيرويدات فى حوامل دهنية نانوميترية Fatma Samir Abdelsalam Elsebaei ; Supervised Seham A. Elkheshen , Hussein O. Ammar - Cairo : Fatma Samir Abdelsalam Elsebaei , 2013 - 217 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
The term autoimmune disease refers to a varied group of illnesses. More than 80% of these serious chronic illnesses involve almost every human organ system. Lupus erythematosus (LE) which is an autoimmune disease may affect joints, heart, lung, kidneys and blood cells, it may also attack skin and it is called cutaneous lupus erythematosus (CLE). CLE includes a variety of specific skin lesions that are subdivided, based on clinical morphology, average duration of skin lesions and routine histopathological examination, into three categories: chronic CLE where discoid lesions are the most common manifestation called discoid lupus erythematosus (DLE), sub acute CLE (SCLE) and acute CLE (ACLE)
Autoimmune disease Corticosteroid drug Nanostructured lipid carrier
Formulation of a corticosteroid drug in nanostructured lipid carrier / صياغة احد الكورتيكوستيرويدات فى حوامل دهنية نانوميترية Fatma Samir Abdelsalam Elsebaei ; Supervised Seham A. Elkheshen , Hussein O. Ammar - Cairo : Fatma Samir Abdelsalam Elsebaei , 2013 - 217 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics
The term autoimmune disease refers to a varied group of illnesses. More than 80% of these serious chronic illnesses involve almost every human organ system. Lupus erythematosus (LE) which is an autoimmune disease may affect joints, heart, lung, kidneys and blood cells, it may also attack skin and it is called cutaneous lupus erythematosus (CLE). CLE includes a variety of specific skin lesions that are subdivided, based on clinical morphology, average duration of skin lesions and routine histopathological examination, into three categories: chronic CLE where discoid lesions are the most common manifestation called discoid lupus erythematosus (DLE), sub acute CLE (SCLE) and acute CLE (ACLE)
Autoimmune disease Corticosteroid drug Nanostructured lipid carrier